Dismiss Modal

Colorectal cancer is the second leading cause of cancer death in the U.S., but new research on regular aspirin use shows promise in lowering your risk of the disease. The study followed more than 10,000 adults who took aspirin regularly and compared them to those who did not.

Research showed that aspirin had a positive response on those who took it, however those with less-healthy, sedentary lifestyles benefited the most. A daily low-dose (81 mg) of aspirin had the best outcomes and worked best to lower the risk of developing colorectal cancer. Inflammation is a key indicator and risk factor for colon cancer, and aspirin works to reduce inflammation and to inhibit cancer growth, which can directly affect how the immune system responds to cancer cells. Aspirin also promotes growth of good bacteria in the gut which can help prevent colorectal cancer development and progression.

More research is underway to determine the effectiveness of aspirin against other types of cancer. Doctors often use caution in recommending the use of aspirin due to the potential side effects including increased risk of bleeding. Your doctor can help you weigh the risks and benefits based on your family history and preexisting health conditions. 
 

Baton Rouge General

Tags
Cancer